Holen Sie sich die Stockscreener-App
1.37
6.80%
-0.10
Schlusskurs vom Vortag:
$1.47
Offen:
$1.38
24-Stunden-Volumen:
989.47K
Relative Volume:
0.09
Marktkapitalisierung:
$54.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.62M
KGV:
-2.0642
EPS:
-0.6637
Netto-Cashflow:
$-15.42M
1W Leistung:
-2.14%
1M Leistung:
+3.01%
6M Leistung:
-3.52%
1J Leistung:
-32.18%
1-Tages-Spanne:
$1.357
$1.44
1-Wochen-Bereich:
$1.32
$1.65
52-Wochen-Spanne:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Firmenname
Heartbeam Inc
Sektor
Branche
Telefon
408-899-4443
Adresse
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.37 | 58.97M | 0 | -20.62M | -15.42M | -0.6637 |
|
VEEV
Veeva Systems Inc
|
179.43 | 29.72B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
50.60 | 8.85B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.22 | 7.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
76.82 | 6.56B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.13 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-31 | Eingeleitet | Roth Capital | Buy |
| 2020-09-11 | Eingeleitet | Needham | Buy |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-08-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Bestätigt | Dougherty & Company | Buy |
| 2018-07-26 | Bestätigt | Lake Street | Buy |
| 2018-04-26 | Bestätigt | The Benchmark Company | Buy |
| 2018-02-23 | Bestätigt | Dougherty & Company | Buy |
| 2017-11-08 | Bestätigt | Dougherty & Company | Buy |
| 2017-10-26 | Eingeleitet | Raymond James | Outperform |
| 2017-10-24 | Eingeleitet | SunTrust | Buy |
| 2017-08-09 | Bestätigt | Dougherty & Company | Buy |
| 2017-07-19 | Bestätigt | The Benchmark Company | Buy |
| 2017-04-11 | Bestätigt | Dougherty & Company | Buy |
| 2016-12-02 | Eingeleitet | Dougherty & Company | Buy |
| 2016-09-13 | Eingeleitet | Sidoti | Buy |
| 2016-08-03 | Bestätigt | The Benchmark Company | Buy |
| 2015-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2013-10-24 | Eingeleitet | The Benchmark Company | Buy |
| 2013-08-21 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2025 Earnings Call Transcript - Insider Monkey
HeartBeam (NASDAQ: BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - USA Today
HeartBeam Q4 2025 slides: FDA clearances fuel commercial launch - Investing.com India
Earnings call transcript: HeartBeam Q4 2025 misses EPS, stock rises - Investing.com
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript - AOL.com
BEAT: FDA-cleared at-home ECG, new partnerships, and improved cash position drive growth - TradingView
HeartBeam Reports Fourth Quarter and Full Year 2025 Results - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio - USA Today
HeartBeam (NASDAQ: BEAT) Management to Participate in March 2026 Investor and Industry Conferences - USA Today
Panic Selling: Can HeartBeam Inc outperform in the next rally2026 Historical Comparison & Proven Capital Preservation Tips - baoquankhu1.vn
HeartBeam announces first commercial customer as ClearCardio brings groundbreaking 12-lead ECG technology to high-growth preventive cardiology market - MSN
Heartbeam Stock Jumps After AI Collaboration With Mount Sinai - Bitget
HeartBeam advances portable cardiac monitoring platform after FDA clearance - DOTmed
HeartBeam partners with Mount Sinai on AI-ECG development By Investing.com - Investing.com South Africa
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study - Stocktwits
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home - Stocktwits
HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market - Stocktwits
HeartBeam (BEAT) Collaborates With Mount Sinai to Advance AI-ECG Algorithm Development - NewMediaWire
Heartbeam Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Heartbeam stock jumps after AI collaboration with Mount Sinai - MSN
HeartBeam partners with Mount Sinai on AI-ECG development - Investing.com Nigeria
HeartBeam and Mount Sinai Announce Strategic AI Collaboration - Medical Product Outsourcing
HeartBeam Enters Commercial Market, Boosts Cardiovascular Technology Horizons - timothysykes.com
HeartBeam to present at March investor conferences By Investing.com - Investing.com Canada
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch - Bluefield Daily Telegraph
Aug EndMonth: Is HeartBeam Inc. a cyclical or defensive stock2026 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Market Outlook: Can HeartBeam Inc maintain its current growth rate2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why HeartBeam Inc. stock attracts high net worth investorsOil Prices & Weekly Setup with ROI Potential - Naître et grandir
Support Test: What are HeartBeam Inc Equity Warrants recent SEC filings showingSwing Trade & Weekly Chart Analysis and Guides - baoquankhu1.vn
ClearCardio, HeartBeam Team Up to Bring 12-Lead ECG Technology to Preventive Cardiology Market - Diagnostic and Interventional Cardiology
HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - NewMediaWire
HeartBeam (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection - Digital Journal
HeartBeam Enrolls 1st Patients in ALIGN-ACS Heart Attack Study - Medical Product Outsourcing
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time - ChartMill
HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio - Yahoo Finance
HeartBeam (NASDAQ: BEAT) Upgraded to Buy as New Joseph Gunnar Report Raises Price Target - Digital Journal
BEAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HeartBeam (NASDAQ: BEAT) Showcased for Advancing Innovative ECG Platform - Digital Journal
BEAT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
HeartBeam (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year - Digital Journal
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - USA Today
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - USA Today
Risk On: Is SQNS stock a hidden gemMarket Sentiment Report & Daily Entry Point Alerts - baoquankhu1.vn
HeartBeam (BEAT) Price Target Increased by 16.22% to 5.48 - Nasdaq
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - USA Today
Breakout Move: What are HeartBeam Inc Equity Warrants recent SEC filings showingEarnings Growth Report & Smart Money Movement Alerts - baoquankhu1.vn
Will HeartBeam Inc. benefit from rising consumer demand2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
HeartBeam (BEAT) Showcased for Advancing Innovative ECG Platform - NewMediaWire
Finanzdaten der Heartbeam Inc-Aktie (BEAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):